The FDA Approval landscape for essential thrombocythemia (ET) is continuing to evolve as researchers and hematologists gain a better understanding of the biology of myeloproliferative neoplasms (MPNs). A significant recent development is the U.S. Food and Drug Administration (FDA) approval of ropeginterferon alfa-2b-njft (Besremi) for the treatment of adults with essential thrombocythemia. The approval was […]

What Are Research Peptides? Research peptides are short chains of amino acids designed primarily for scientific study and experimental applications. Unlike therapeutic peptides meant for clinical use, these compounds serve as tools in biochemistry, molecular biology, and pharmacology to help researchers explore cellular mechanisms, receptor interactions, and signaling pathways. In simple terms, research peptides are […]